HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Australian hemophiliac recipients of voluntary donor blood products longitudinally evaluated for AIDS. A clinical and laboratory study, 1983-1986.

Abstract
One hundred and sixty-one Australian patients with hereditary bleeding disorders comprising hemophilia A (120), hemophilia B (18), von Willebrand's disease (16), and seven symptomatic female hemophilia A or B carriers were screened for clinical and serological evidence of exposure to HTLV-III/LAV/ARV/HIV infection. During the previous five years (1979-1984) they had been treated almost exclusively with blood products derived from Australian voluntary donors. The prevalence of HTLV-III antibodies in 1985 was 45%, with the highest frequency being in those with severe hemophilia A (78%) and the lowest in patients with hemophilia B (6%). Antibody positivity correlated with a reduced absolute T helper (T4) cell numbers and/or an inverted T4:T8 ratio. Lymphadenopathy was detected in 23 subjects but only 13 had an abnormal T cell ratio. Comparison of seropositivity and T4:T8 ratios in 32 patients studied in 1983 and again in 1985 suggested that T4 cell deficiency reflected HTLV-III exposure rather than being a predisposing factor for infection with the virus. Individual patients showed considerable fluctuation in T cell subsets over a 12 month period of follow-up, but as a population there was a slight trend with time towards diminishing T4:T8 ratio only in the antibody positive hemophilia A patients of mild to moderate severity. Three (2%) of the 161 patients screened to date have developed confirmed AIDS with fatal outcome.(ABSTRACT TRUNCATED AT 250 WORDS)
AuthorsR J Garsia, P A Gatenby, A Basten, D F Kenny, K J Gallagher, K A Rickard, I D Gust, W Maskill
JournalAustralian and New Zealand journal of medicine (Aust N Z J Med) Vol. 17 Issue 4 Pg. 371-8 (Aug 1987) ISSN: 0004-8291 [Print] Australia
PMID2963611 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Viral
  • Blood Coagulation Factors
  • HIV Antibodies
Topics
  • Acquired Immunodeficiency Syndrome (immunology, transmission)
  • Antibodies, Viral (analysis)
  • Australia
  • Blood Coagulation Factors (therapeutic use)
  • Blood Donors
  • Blood Transfusion
  • Female
  • Follow-Up Studies
  • HIV (immunology)
  • HIV Antibodies
  • HIV Seropositivity (immunology)
  • Hemophilia A (immunology, therapy)
  • Humans
  • Leukocyte Count
  • Male
  • Risk Factors
  • T-Lymphocytes, Helper-Inducer (immunology)
  • T-Lymphocytes, Regulatory (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: